Here’s What Analysts Think About Biogen Inc. (BIIB)
Biogen Inc. (NASDAQ:BIIB) is one of the best performing pharma stocks in 2025. Biogen Inc. (NASDAQ:BIIB) received several rating updates on ...
Thursday, April 9, 2026
Tag: BIIB
Biogen – BIIB: Leqembi erhält Zulassungen in China & Australien!
Pullback-Setup mit Bullenflagge! Neuausrichtung bei Biogen (BIIB): Alcyone Therapeutics für rund 85 Millionen USD übernommen & Rückzug aus AAV-basierten Gentherapieprojekten! ...
BIIB Earnings: Highlights of Biogen’s Q2 2025 results
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) on Thursday reported higher revenues and adjusted profit for the second quarter of 2025. ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.